AbbVie is a big company that makes medicine. Some people who watch the stock market think the price of AbbVie's stock will go up or down. They buy and sell options, which are like bets on the stock price. They are more interested in buying options that will make them money if the stock goes up. We looked at the options they bought and sold, and saw that many people think the stock will go up. The stock price is now $187.31, which is higher than the average price of $182.73 that people were willing to pay for the stock in the past. Some experts think the stock will go higher and others think it will go lower, but most of them think it will go higher. Read from source...

- The headline is misleading and does not reflect the actual content of the article, which is a technical analysis of options trading, not a closer look at AbbVie's options market dynamics.
- The article body is mostly focused on the details of the options trades, which may not be relevant or useful for general readers who are interested in the company's fundamentals and outlook.
- The article uses confusing and unclear terms, such as "volume and open interest", "options history", "analysis of options history", "unusual trades", without explaining what they mean or how they are calculated.
- The article does not provide any context or background information about AbbVie, its industry, its products, its performance, its challenges, its opportunities, its strategy, its valuation, etc. This makes it hard for readers to understand why the options trading activity matters and what it implies for the company's future direction.
- The article jumps from options trading to the company's current position and analyst ratings, without connecting the dots or explaining the relationship between the two. This makes it disjointed and confusing for readers who want to get a holistic view of the company.
- The article ends with a promotional pitch for Benzinga Pro, which is irrelevant and intrusive for readers who are not interested in subscribing to the service. This also undermines the credibility and objectivity of the article.